CVS Health Enterprise Value Trend

CVS -- USA Stock  

Fiscal Quarter End: December 31, 2019  

This module enables investors to look at CVS Health various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Direct Expenses of 132.3 B, Consolidated Income of 4.2 B or Cost of Revenue of 106.2 B, but also many exotic indicators such as Interest Coverage of 7.0765, Long Term Debt to Equity of 0.86 or Calculated Tax Rate of 95.2946. This module is a perfect complement to use when analyzing CVS Health Valuation or Volatility. It can also complement various CVS Health Technical models. Check also analysis of CVS Health Correlation with competitors.

CVS Health Enterprise Value Marginal Breakdown

Showing smoothed Enterprise Value of CVS Health Corporation with missing and latest data points interpolated. Enterprise Value (or EV) is usually referred to as CVS Health theoretical takeover price. In the event of an acquisition, an acquirer would have to take on CVS Health debt, but would also pocket its cash. Enterprise Value is more accurate representation of CVS Health value than its market capitalization because it takes into account all of CVS Health Corporation existing debt. Enterprise value is a measure of the value of a business as a whole; calculated as [MarketCap] plus [DebtUSD] minus [CashnEqUSD].

171.47 B

          10 Years Trend
Slightly volatile
 Enterprise Value 

CVS Health Regression Statistics

Arithmetic Mean 64,952,283,555
Geometric Mean 59,361,330,453
Coefficient Of Variation 57.18
Mean Deviation 23,566,572,475
Median 49,721,792,720
Standard Deviation 37,142,578,973
Range 121,748,207,280
R Value 0.36
R Squared 0.13
Significance 0.27
Slope 4,062,995,427

CVS Health Enterprise Value Over Time

2010  49,721,792,720 
2018  57,180,061,628 
2019  171,470,000,000 

Other Fundumenentals of CVS Health